BNGO
insider transactionsBionano Genomics, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Other·F
GENERAL COUNSEL
$31
24 sh · $1.30
Own -9%
-
Other·F
CHIEF MEDICAL OFFICER
$31
24 sh · $1.30
Own -4%
-
Other·F
CHIEF OPERATING OFFICER
$35
27 sh · $1.30
Own -3%
-
Other·F
Principal Accounting Officer
$9
7 sh · $1.30
Own -3%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 3, 2026 | Jonathan V. Dixon | Other F | 24 | $31 |
| Jun 3, 2026 | Alka Chaubey | Other F | 24 | $31 |
| Jun 3, 2026 | Mark Oldakowski | Other F | 27 | $35 |
| Jun 3, 2026 | Mark Adamchak | Other F | 7 | $9 |
About BNGO insider trading
This page tracks insider transactions for Bionano Genomics, Inc. (BNGO) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.